Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 2, 2008
Deleterious effect of unintentional pacing from the middle cardiac vein in a patient with congenitally corrected transposition of the great arteries and ventricular septal defect. The beneficial effect of cardiac resynchronization therapy after heart surgeryAndrzej Przybylski, Mirosław Kowalski, Aleksander Maciag, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 1, 2004
[Successful radiofrequency catheter ablation of the symptomatic ventricular tachycardia in structurally normal heart. Case report]Aleksander Maciag, Maciej Sterliński, Mariusz Pytkowski, et al.
Kardiologia Polska|November 8, 2005
[Thrombus visualisation during radiofrequency catheter ablation. A case report]Aleksander Maciag, Hanna Szwed, Mariusz Pytkowski, et al.
Kardiologia Polska|June 2, 2005
[Acute myocardial infarction complicated by cardiogenic shock in a patient with Leriche syndrome--a case report]Anna Borowiec-Kocańda, Jacek Woźniak, Aleksander Maciag, et al.
Kardiologia Polska|November 8, 2006
[From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report]Katarzyna Gepner, Maciej Sterliński, Andrzej Przybylski, et al.
British Journal of Clinical Pharmacology|March 29, 2019
Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study)Michal M Farkowski, Aleksander Maciag, Ilona Kowalik, et al.
Trials|September 13, 2012
Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study)Michal M Farkowski, Aleksander Maciag, Rafal Dabrowski, et al.
Cardiovascular Therapeutics|October 4, 2018
Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency departmentMichal M Farkowski, Aleksander Maciag, Malgorzata Zurawska, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 22, 2008
Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delayMariusz Pytkowski, Agnieszka Jankowska, Aleksander Maciag, et al.
Kardiologia Polska|June 13, 2009
Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary resultsAndrzej Przybylski, Joanna Zakrzewska-Koperska, Aleksander Maciag, et al.
Pageof 3